What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Tuberculosis
- Disease
Madhukar Pai mainly investigates Tuberculosis, Immunology, Internal medicine, Tuberculosis diagnosis and Meta-analysis.
His Intensive care medicine research extends to Tuberculosis, which is thematically connected.
His Immunology research incorporates themes from Systematic review and Environmental health.
His Internal medicine research is multidisciplinary, relying on both Extrapulmonary tuberculosis, Surgery and Rifampicin.
The concepts of his Tuberculosis diagnosis study are interwoven with issues in Emerging technologies and Pediatrics.
His Meta-analysis research integrates issues from Nucleic Acid Amplification Tests, Drug resistance and Isoniazid.
His most cited work include:
- Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. (1090 citations)
- Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. (883 citations)
- Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review (827 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Tuberculosis, Internal medicine, Immunology, Intensive care medicine and Mycobacterium tuberculosis.
Madhukar Pai combines subjects such as Health care and Family medicine with his study of Tuberculosis.
His Internal medicine research incorporates elements of Surgery, Rifampicin and Isoniazid.
His Immunology study frequently links to other fields, such as Virology.
His research integrates issues of Disease and Pathology in his study of Intensive care medicine.
His studies deal with areas such as Sputum and Drug resistance as well as Mycobacterium tuberculosis.
He most often published in these fields:
- Tuberculosis (81.88%)
- Internal medicine (23.99%)
- Immunology (20.30%)
What were the highlights of his more recent work (between 2017-2021)?
- Tuberculosis (81.88%)
- Internal medicine (23.99%)
- Intensive care medicine (15.60%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Tuberculosis, Internal medicine, Intensive care medicine, Global health and Health care.
Madhukar Pai interconnects Quality, Environmental health, Private sector, Family medicine and Public health in the investigation of issues within Tuberculosis.
His Private sector research includes themes of Cross-sectional study and Quality management.
His Internal medicine study often links to related topics such as Rifampicin resistance.
His Intensive care medicine research is multidisciplinary, relying on both Tuberculosis diagnosis, Disease, Active tuberculosis and Lipoarabinomannan.
The various areas that Madhukar Pai examines in his Global health study include Developing country and Pandemic, Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2.
Between 2017 and 2021, his most popular works were:
- Building a tuberculosis-free world: The Lancet Commission on tuberculosis (118 citations)
- Xpert MTB/RIF and Xpert MTB/RIF Ultra for Pulmonary Tuberculosis and Rifampicin Resistance in Adults (57 citations)
- Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities. (56 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Tuberculosis
Madhukar Pai spends much of his time researching Tuberculosis, Global health, Intensive care medicine, Internal medicine and Tuberculosis diagnosis.
His research in Tuberculosis intersects with topics in Cohort study, Environmental health, Cross-sectional study, Private sector and Disease.
Medical prescription, Medical record and Prevalence is closely connected to Developing country in his research, which is encompassed under the umbrella topic of Global health.
His studies deal with areas such as Control, Ingredient, Regimen and Active tuberculosis as well as Intensive care medicine.
His Internal medicine study combines topics from a wide range of disciplines, such as GeneXpert MTB/RIF, Pulmonary tuberculosis and Viral load.
His work carried out in the field of Pulmonary tuberculosis brings together such families of science as Rifampicin resistance, Mycobacterium tuberculosis, Antibiotics and Drug resistance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
